Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
Related Posts
‘It’s All About Trump’s Tariffs’: Asia Flocks to U.S. Trade Official
Asia Pacific Economic Cooperation nations, staring down U.S. tariffs, jockeyed for time with U.S. Trade Representative Jamieson Greer at a gathering in South Korea.
Top N.I.H. Official Abruptly Resigns as Trump Orders Deep Cuts
Dr. Lawrence Tabak, the No. 2 official at the National Institutes of Health, did not give a reason for his departure.
Long-Term Investing Has Gotten Riskier as Trump’s Tariffs Shake the Markets
President Trump’s policies have shaken the markets. Protect yourself first, and, only then, take advantage of investment bargains, our columnist says.